NYSE:CO

Global Cord Blood Competitors

$4.81
+0.06 (+1.26 %)
(As of 04/16/2021 04:00 PM ET)
Add
Compare
Today's Range
$4.66
Now: $4.81
$4.82
50-Day Range
$4.16
MA: $4.61
$4.92
52-Week Range
$2.54
Now: $4.81
$4.98
Volume303,754 shs
Average Volume266,932 shs
Market Capitalization$584.66 million
P/E Ratio8.15
Dividend YieldN/A
Beta0.39

Competitors

Global Cord Blood (NYSE:CO) Vs. IPOE, IPOF, PAYA, WPF, PRCH, and STPK

Should you be buying CO stock or one of its competitors? Companies in the industry of "holding & other investment offices" are considered alternatives and competitors to Global Cord Blood, including Social Capital Hedosophia Holdings Corp. V (IPOE), Social Capital Hedosophia Holdings Corp. VI (IPOF), Paya (PAYA), Foley Trasimene Acquisition (WPF), Porch Group (PRCH), and Star Peak Energy Transition (STPK).

Social Capital Hedosophia Holdings Corp. V (NYSE:IPOE) and Global Cord Blood (NYSE:CO) are both small-cap unclassified companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, earnings, valuation, risk and analyst recommendations.

Profitability

This table compares Social Capital Hedosophia Holdings Corp. V and Global Cord Blood's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Social Capital Hedosophia Holdings Corp. VN/AN/AN/A
Global Cord Blood42.17%12.77%6.91%

Analyst Recommendations

This is a breakdown of current ratings and target prices for Social Capital Hedosophia Holdings Corp. V and Global Cord Blood, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Social Capital Hedosophia Holdings Corp. V0000N/A
Global Cord Blood0000N/A

Valuation & Earnings

This table compares Social Capital Hedosophia Holdings Corp. V and Global Cord Blood's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Social Capital Hedosophia Holdings Corp. VN/AN/AN/AN/AN/A
Global Cord Blood$172.50 million3.39$66.48 millionN/AN/A

Global Cord Blood has higher revenue and earnings than Social Capital Hedosophia Holdings Corp. V.

Summary

Global Cord Blood beats Social Capital Hedosophia Holdings Corp. V on 4 of the 4 factors compared between the two stocks.

Global Cord Blood (NYSE:CO) and Social Capital Hedosophia Holdings Corp. VI (NYSE:IPOF) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, earnings, institutional ownership and dividends.

Profitability

This table compares Global Cord Blood and Social Capital Hedosophia Holdings Corp. VI's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Global Cord Blood42.17%12.77%6.91%
Social Capital Hedosophia Holdings Corp. VIN/AN/AN/A

Analyst Recommendations

This is a summary of current ratings and recommmendations for Global Cord Blood and Social Capital Hedosophia Holdings Corp. VI, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Global Cord Blood0000N/A
Social Capital Hedosophia Holdings Corp. VI0000N/A

Valuation & Earnings

This table compares Global Cord Blood and Social Capital Hedosophia Holdings Corp. VI's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Global Cord Blood$172.50 million3.39$66.48 millionN/AN/A
Social Capital Hedosophia Holdings Corp. VIN/AN/AN/AN/AN/A

Global Cord Blood has higher revenue and earnings than Social Capital Hedosophia Holdings Corp. VI.

Summary

Global Cord Blood beats Social Capital Hedosophia Holdings Corp. VI on 4 of the 4 factors compared between the two stocks.

Global Cord Blood (NYSE:CO) and Paya (NASDAQ:PAYA) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, earnings, institutional ownership and dividends.

Risk and Volatility

Global Cord Blood has a beta of 0.39, meaning that its stock price is 61% less volatile than the S&P 500. Comparatively, Paya has a beta of 0.05, meaning that its stock price is 95% less volatile than the S&P 500.

Profitability

This table compares Global Cord Blood and Paya's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Global Cord Blood42.17%12.77%6.91%
PayaN/A-1.98%-0.03%

Analyst Recommendations

This is a summary of current ratings and recommmendations for Global Cord Blood and Paya, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Global Cord Blood0000N/A
Paya00503.00

Paya has a consensus price target of $15.75, suggesting a potential upside of 39.38%. Given Paya's higher possible upside, analysts clearly believe Paya is more favorable than Global Cord Blood.

Valuation & Earnings

This table compares Global Cord Blood and Paya's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Global Cord Blood$172.50 million3.39$66.48 millionN/AN/A
PayaN/AN/A$4.28 million$0.1863.17

Global Cord Blood has higher revenue and earnings than Paya.

Institutional and Insider Ownership

41.2% of Paya shares are held by institutional investors. 1.5% of Paya shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Global Cord Blood beats Paya on 6 of the 11 factors compared between the two stocks.

Global Cord Blood (NYSE:CO) and Foley Trasimene Acquisition (NYSE:WPF) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, earnings, institutional ownership and dividends.

Profitability

This table compares Global Cord Blood and Foley Trasimene Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Global Cord Blood42.17%12.77%6.91%
Foley Trasimene AcquisitionN/AN/AN/A

Analyst Recommendations

This is a summary of current ratings and recommmendations for Global Cord Blood and Foley Trasimene Acquisition, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Global Cord Blood0000N/A
Foley Trasimene Acquisition0000N/A

Valuation & Earnings

This table compares Global Cord Blood and Foley Trasimene Acquisition's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Global Cord Blood$172.50 million3.39$66.48 millionN/AN/A
Foley Trasimene AcquisitionN/AN/AN/AN/AN/A

Global Cord Blood has higher revenue and earnings than Foley Trasimene Acquisition.

Institutional and Insider Ownership

0.1% of Foley Trasimene Acquisition shares are held by institutional investors. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Global Cord Blood beats Foley Trasimene Acquisition on 4 of the 5 factors compared between the two stocks.

Global Cord Blood (NYSE:CO) and Porch Group (NASDAQ:PRCH) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, earnings, institutional ownership and dividends.

Profitability

This table compares Global Cord Blood and Porch Group's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Global Cord Blood42.17%12.77%6.91%
Porch GroupN/AN/AN/A

Institutional and Insider Ownership

97.8% of Porch Group shares are held by institutional investors. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Global Cord Blood and Porch Group, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Global Cord Blood0000N/A
Porch Group00303.00

Porch Group has a consensus price target of $25.3333, suggesting a potential upside of 61.98%. Given Porch Group's higher possible upside, analysts clearly believe Porch Group is more favorable than Global Cord Blood.

Valuation & Earnings

This table compares Global Cord Blood and Porch Group's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Global Cord Blood$172.50 million3.39$66.48 millionN/AN/A
Porch GroupN/AN/AN/AN/AN/A

Global Cord Blood has higher revenue and earnings than Porch Group.

Summary

Global Cord Blood beats Porch Group on 4 of the 7 factors compared between the two stocks.

Global Cord Blood (NYSE:CO) and Star Peak Energy Transition (NYSE:STPK) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, risk, profitability, institutional ownership and earnings.

Profitability

This table compares Global Cord Blood and Star Peak Energy Transition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Global Cord Blood42.17%12.77%6.91%
Star Peak Energy TransitionN/AN/AN/A

Analyst Ratings

This is a summary of current ratings for Global Cord Blood and Star Peak Energy Transition, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Global Cord Blood0000N/A
Star Peak Energy Transition0000N/A

Earnings and Valuation

This table compares Global Cord Blood and Star Peak Energy Transition's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Global Cord Blood$172.50 million3.39$66.48 millionN/AN/A
Star Peak Energy TransitionN/AN/AN/AN/AN/A

Global Cord Blood has higher revenue and earnings than Star Peak Energy Transition.

Summary

Global Cord Blood beats Star Peak Energy Transition on 4 of the 4 factors compared between the two stocks.


Global Cord Blood Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
IPOE
Social Capital Hedosophia Holdings Corp. V
0.5$16.20+0.5%$1.64 billionN/A0.00
IPOF
Social Capital Hedosophia Holdings Corp. VI
0.0$10.42+0.7%$1.51 billionN/A0.00Decrease in Short Interest
Paya logo
PAYA
Paya
2.1$11.37+0.3%$1.44 billionN/A142.14
WPF
Foley Trasimene Acquisition
0.0$10.01+0.1%$1.29 billionN/A0.00Increase in Short Interest
Porch Group logo
PRCH
Porch Group
1.9$14.36+12.0%$1.28 billionN/A0.00
STPK
Star Peak Energy Transition
0.2$25.62+1.9%$1.25 billionN/A0.00
Arko logo
ARKO
Arko
1.9$9.95+0.4%$1.24 billionN/A0.00Increase in Short Interest
JWS
Jaws Acquisition
0.2$13.19+0.6%$1.14 billionN/A0.00Increase in Short Interest
Brooge Energy logo
BROG
Brooge Energy
0.8$10.05+5.5%$1.10 billion$44.08 million31.41Gap Up
CRHC
Cohn Robbins
0.0$10.05+0.4%$1.04 billionN/A0.00
Bain Capital Specialty Finance logo
BCSF
Bain Capital Specialty Finance
1.2$15.68+0.4%$1.01 billion$197.95 million-38.24Increase in Short Interest
APSG
Apollo Strategic Growth Capital
0.0$9.92+0.1%$1.01 billionN/A0.00Decrease in Short Interest
GSAH
GS Acquisition Holdings Corp II
0.4$10.32+0.8%$975 millionN/A0.00Decrease in Short Interest
CONX
CONX
0.0$10.00+0.5%$942.39 millionN/A0.00News Coverage
Artius Acquisition logo
AACQ
Artius Acquisition
0.2$10.01+0.3%$906.54 millionN/A0.00Increase in Short Interest
News Coverage
RTP
Reinvent Technology Partners
0.0$10.07+0.3%$868.54 millionN/A0.00Increase in Short Interest
PRPB
CC Neuberger Principal Holdings II
0.0$10.03+0.3%$830.48 millionN/A0.00
AGC
Altimeter Growth
0.0$12.52+7.9%$779.37 millionN/A0.00Unusual Options Activity
Gap Up
HighPeak Energy logo
HPK
HighPeak Energy
0.0$7.96+3.4%$762.72 millionN/A0.00Decrease in Short Interest
Gap Up
AVAN
Avanti Acquisition
0.0$9.97+0.2%$749.25 millionN/A0.00Decrease in Short Interest
News Coverage
RBAC
RedBall Acquisition
0.0$10.01+1.1%$727.38 millionN/A0.00Increase in Short Interest
News Coverage
DGNR
Dragoneer Growth Opportunities
0.0$10.14+0.3%$699.66 millionN/A0.00
CIIC
CIIG Merger
1.9$21.60+10.2%$698.61 millionN/A0.00
Churchill Capital Corp II logo
CCX
Churchill Capital Corp II
2.0$10.02+0.0%$691.38 millionN/A0.00Analyst Report
Decrease in Short Interest
Horizon Acquisition logo
HZAC
Horizon Acquisition
0.0$9.87+0.4%$673.86 millionN/A0.00Decrease in Short Interest
dMY Technology Group, Inc. II logo
DMYD
dMY Technology Group, Inc. II
1.7$19.61+1.2%$668.61 millionN/A0.00
GRSV
Gores Holdings V
0.0$10.03+0.0%$658.22 millionN/A0.00Decrease in Short Interest
TREB
Trebia Acquisition
0.2$10.05+0.1%$650.76 millionN/A0.00Decrease in Short Interest
VGAC
VG Acquisition
0.0$9.97+0.4%$636.33 millionN/A0.00Unusual Options Activity
IPOD
Social Capital Hedosophia Holdings Corp. IV
0.0$10.77+1.4%$634.80 millionN/A0.00
NGA
Northern Genesis Acquisition
0.0$15.25+1.3%$616.95 millionN/A0.00
ETAC
E.Merge Technology Acquisition
0.0$9.82+0.3%$600.98 millionN/A0.00Decrease in Short Interest
JIH
Juniper Industrial
0.2$13.63+0.1%$588.66 millionN/A0.00
SSPK
Silver Spike Acquisition
0.2$18.37+1.9%$574.04 millionN/A0.00
GOAC
GO Acquisition
0.0$9.97+0.4%$573.28 millionN/A0.00
SEAH
Sports Entertainment Acquisition
0.0$9.96+0.3%$558.56 millionN/A0.00Decrease in Short Interest
ACTC
ArcLight Clean Transition
1.0$15.58+2.1%$540.44 millionN/A0.00
FMAC
FirstMark Horizon Acquisition
0.0$10.09+0.2%$523.19 millionN/A0.00
CCAP
Crescent Capital BDC
1.4$18.53+2.6%$521.94 million$53.48 million18.91
EQD
Equity Distribution Acquisition
0.0$9.95+0.4%$514.91 millionN/A0.00Decrease in Short Interest
News Coverage
ACND
Ascendant Digital Acquisition
0.0$9.92+0.1%$513.36 millionN/A0.00
IMPX
AEA-Bridges Impact
0.0$9.93+0.3%$498 millionN/A0.00Increase in Short Interest
APXT
Apex Technology Acquisition
1.0$11.09+3.3%$494.17 millionN/A0.00
BTAQ
Burgundy Technology Acquisition
0.0$9.91+0.4%$439.67 millionN/A0.00Decrease in Short Interest
LSEA
Landsea Homes
1.9$9.30+2.2%$439.19 millionN/A0.00Increase in Short Interest
VACQ
Vector Acquisition
0.0$10.90+3.4%$436 millionN/A0.00Decrease in Short Interest
SNPR
Tortoise Acquisition Corp. II
0.0$10.02+0.9%$435.99 millionN/A0.00
Fusion Acquisition logo
FUSE
Fusion Acquisition
0.2$9.91+0.5%$435.75 millionN/A0.00News Coverage
DEH
D8
0.2$9.97+1.0%$434.27 millionN/A0.00Decrease in Short Interest
News Coverage
Thunder Bridge Acquisition II logo
THBR
Thunder Bridge Acquisition II
1.9$10.07+0.2%$433.36 millionN/A0.00Decrease in Short Interest
This page was last updated on 4/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.